Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis

Trends Pharmacol Sci. 2003 Oct;24(10):530-4. doi: 10.1016/j.tips.2003.08.001.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Arteriosclerosis / drug therapy
  • Arteriosclerosis / metabolism*
  • Disease Models, Animal*
  • Drug Evaluation, Preclinical
  • Drugs, Investigational / pharmacology*
  • Hyperlipidemias / drug therapy
  • Hyperlipidemias / metabolism*
  • Hypolipidemic Agents / pharmacology
  • Hypolipidemic Agents / therapeutic use
  • Ligands
  • Mice
  • Receptors, Cytoplasmic and Nuclear / agonists
  • Receptors, Cytoplasmic and Nuclear / metabolism*
  • Transcription Factors / agonists
  • Transcription Factors / metabolism*

Substances

  • Drugs, Investigational
  • Hypolipidemic Agents
  • Ligands
  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors